Agency Forms Undergoing Paperwork Reduction Act Review, 28516-28517 [2014-11311]
Download as PDF
<![CDATA[
28516
Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices
which would ideally leave us with 30
BG4 participants, 60 mine rescue
participants (MRET Lab), 60 mine
escape participants (MRET Lab), and 60
mine escape participants (classroom
setting), for a new grand total of 210
participants.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number
responses
per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Type of respondent
Form name
¨
Drager BG4 participants (i.e., closed
circuit breathing apparatus training
participants).
Mine Rescue participants .....................
Pre-Training Questionnaire ..................
30
1
3/60
2
Pre-Training Questionnaire ..................
Post-Simulation Questionnaire .............
Post-Training Questionnaire ................
Pre-Training Questionnaire ..................
Post-Simulation Questionnaire (MRET
Lab version).
Post-Simulation Questionnaire (Field
Test Version).
Post-Training Questionnaire ................
Pre/Post-Training Knowledge Test ......
60
60
60
120
60
1
1
1
1
1
3/60
3/60
3/60
3/60
3/60
3
3
3
6
3
60
1
3/60
3
120
60
1
1
3/60
6/60
6
6
Pre/Post-Training Knowledge Test ......
60
1
6/60
6
Pre/Post-Training Knowledge Test ......
30
1
6/60
3
Pre/Post-Training Knowledge Test ......
30
1
6/60
3
...............................................................
......................
......................
......................
47
Mine Escape participants ......................
Mine Escape/Longwall Mining participants.
Mine Escape/Continuous Mining participants.
Mine Rescue/Longwall Mining participants.
Mine Rescue/Continuous Mining participants.
Total ...............................................
LeRoy A. Richardson
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11313 Filed 5–15–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–14–0006]
EMCDONALD on DSK67QTVN1PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
VerDate Mar<15>2010
20:00 May 15, 2014
Jkt 232001
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Proposed Project
Statements in Support of Application
of Waiver of Inadmissibility (0920–
0006)—Extension—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Section 212(a)(1) of the Immigration
and Nationality Act states that aliens
with specific health related conditions
are ineligible for admission into the
United States. The Attorney General
may waive application of this
inadmissibility on health-related
grounds if an application for waiver is
filed and approved by the consular
office considering the application for
visa. CDC uses this application
primarily to collect information to
establish and maintain records of waiver
applicants in order to notify the U.S.
Citizenship and Immigration Services
when terms, conditions and controls
imposed by waiver are not met.
CDC is requesting approval from OMB
to collect this data for another 3 years.
There are no costs to respondents except
their time to complete the application.
The annualized burden for this data
collection is 100 hours.
E:\FR\FM\16MYN1.SGM
16MYN1
28517
Federal Register / Vol. 79, No. 95 / Friday, May 16, 2014 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS
Type of respondent
Form
Physician .......................................................................................................
Physician .......................................................................................................
LeRoy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11311 Filed 5–15–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control (BSC, NCIPC)
EMCDONALD on DSK67QTVN1PROD with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces, the following meeting of the
aforementioned committee:
Times and Dates: 1:00 p.m.–3:15 p.m., June
5, 2014 (CLOSED). 9:00 a.m.–3:45 p.m., June
6, 2014 (OPEN).
Place: Centers for Disease Control and
Prevention, 4770 Buford Highway NE.,
Chamblee Campus, Building 107, Conference
Room 1–B 01206/1–C 01210, Atlanta,
Georgia.
Status: Portions of the meeting as
designated above will be closed to the public
in accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist other
appropriate public health authorities,
scientific institutions, and scientists in the
conduct of research, investigations,
experiments, demonstrations, and studies
relating to the causes, diagnosis, treatment,
control, and prevention of physical and
mental diseases, and other impairments; (2)
assist States and their political subdivisions
in preventing and suppressing communicable
and non-communicable diseases and other
preventable conditions and in promoting
health and well-being; and (3) conduct and
assist in research and control activities
related to injury.
The Board of Scientific Counselors makes
recommendations regarding policies,
strategies, objectives, and priorities; and
reviews progress toward injury prevention
goals and provides evidence in injury
prevention-related research and programs.
VerDate Mar<15>2010
20:00 May 15, 2014
Jkt 232001
CDC 4.422–1
CDC 4.422–1a
The Board also provides advice on the
appropriate balance of intramural and
extramural research, the structure, progress
and performance of intramural programs. The
Board is designed to provide guidance on
extramural scientific program matters,
including the: (1) Review of extramural
research concepts for funding opportunity
announcements; (2) conduct of Secondary
Peer Review of extramural research grants,
cooperative agreements, and contracts
applications received in response to the
funding opportunity announcements as it
relates to the Center’s programmatic balance
and mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered for
funding support; (4) review of research
portfolios, and (5) review of program
proposals.
Matters for Discussion: On the first day of
the meeting (closed session to the public), the
Board of Scientific Counselors will conduct
the Secondary Peer Review of extramural
research grant applications received in
response to Funding Opportunity
Announcement CE14–001, Grants for Injury
Control Research Centers. Applications will
be assessed for applicability to the Center’s
mission and programmatic balance.
Recommendations from the secondary review
will be voted upon and the applications will
be forwarded to the Acting Center Director
for consideration for funding support.
Open Session: On the second day of the
meeting, the Board will discuss the
following: (1) Update from the Acting
Director, (2) update from the Pediatric Mild
Traumatic Brain Injuries TBI Workgroup
Activities, (3) update on WISQARS (Webbased Injury Statistics Query and Reporting
System) Portfolio Review, and (4) specific
research topics in unintentional injuries and
violence-related injuries for which the
Divisions will be seeking advice and
guidance on proposed and/or current
projects. The exact topics areas are being
determined.
There will be 15 minutes allotted for
public comments at the end of the open
session.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D., M.S.E.H.,
Deputy Associate Director for Science,
NCIPC, CDC, 4770 Buford Highway NE.,
Mailstop F–63, Atlanta, Georgia 30341,
Telephone (770) 488–1430.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00045
Fmt 4703
Number of
respondents
Sfmt 4703
Number of
responses per
respondent
200
200
Average
burden per
response
(in hours)
1
1
10/60
20/60
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–11351 Filed 5–15–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Reduce Hepatitis Infections by
Treatment and Integrated Prevention
Services (Hepatitis-TIPS) among Nonurban Young Persons Who Inject Drugs,
Funding Opportunity Announcement
(FOA) PS14–004, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12:00 p.m.–5:00 p.m., June
10, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Reduce Hepatitis Infections by
Treatment and Integrated Prevention Services
(Hepatitis-TIPS) among Non-urban Young
Persons Who Inject Drugs, FOA PS14–004,
initial review.’’
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H., Scientific
Review Officer, CDC, 1600 Clifton Road NE.,
Mailstop E60, Atlanta, Georgia 30333,
Telephone: (404) 718–8833.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\16MYN1.SGM
16MYN1
]]>Agencies
[Federal Register Volume 79, Number 95 (Friday, May 16, 2014)]
[Notices]
[Pages 28516-28517]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-11311]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-14-0006]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Statements in Support of Application of Waiver of Inadmissibility
(0920-0006)--Extension--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Section 212(a)(1) of the Immigration and Nationality Act states
that aliens with specific health related conditions are ineligible for
admission into the United States. The Attorney General may waive
application of this inadmissibility on health-related grounds if an
application for waiver is filed and approved by the consular office
considering the application for visa. CDC uses this application
primarily to collect information to establish and maintain records of
waiver applicants in order to notify the U.S. Citizenship and
Immigration Services when terms, conditions and controls imposed by
waiver are not met.
CDC is requesting approval from OMB to collect this data for
another 3 years. There are no costs to respondents except their time to
complete the application. The annualized burden for this data
collection is 100 hours.
[[Page 28517]]
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Physician.......................... CDC 4.422-1 200 1 10/60
Physician.......................... CDC 4.422-1a 200 1 20/60
----------------------------------------------------------------------------------------------------------------
LeRoy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-11311 Filed 5-15-14; 8:45 am]
BILLING CODE 4163-18-P
